Clarivate (CLVT) Financials

$4.28 +0.06 (+1.30%)

Closing price 06/16/2025 03:59 PM Eastern

Extended Trading

$4.35 +0.06 (+1.49%)

As of 06/16/2025 07:50 PM Eastern

Annual Income Statements for Clarivate

This table shows Clarivate's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	-264	-242	-259	-351	-312	-4,036	-987	-668
Consolidated Net Income / (Loss)	-264	-242	-259	-351	-271	-3,960	-911	-637
Net Income / (Loss) Continuing Operations	-264	-242	-259	-351	-271	-3,960	-911	-637
Total Pre-Tax Income	-285	-237	-248	-353	-258	-3,989	-1,013	-554
Total Operating Income	-147	-106	-82	-36	-87	-3,926	-735	-276
Total Gross Profit	523	538	622	815	1,251	1,706	1,722	1,688
Total Revenue	918	968	974	1,254	1,877	2,660	2,629	2,557
Operating Revenue	918	968	974	1,254	1,877	2,660	2,629	2,557
Total Cost of Revenue	394	430	352	439	626	954	906	869
Operating Cost of Revenue	394	430	352	439	626	954	906	869
Total Operating Expenses	670	644	705	852	1,338	5,631	2,457	1,963
Selling, General & Admin Expense	343	413	475	545	643	730	740	728
Depreciation Expense	7.00	9.42	9.18	303	538	711	708	727
Other Operating Expenses / (Income)	2.48	-6.38	-4.83	-52	28	-325	-11	-52
Impairment Charge	0.00	0.00	18	0.00	130	4,516	1,020	560
Total Other Income / (Expense), net	-138	-131	-166	-317	-171	-64	-278	-278
Interest & Investment Income	-	-	-	-	-	-270	-294	-283
Other Income / (Expense), net	-	0.00	-8.26	-205	81	207	16	5.20
Income Tax Expense	-21	5.65	10	-2.70	12	-29	-101	83
Preferred Stock Dividends Declared	-	-	0.00	0.00	42	75	75	31
Basic Earnings per Share	($1.22)	($1.11)	($0.94)	($0.82)	($0.49)	($5.97)	($1.47)	($0.96)
Weighted Average Basic Shares Outstanding	216.85M	217.47M	273.88M	427M	631M	676.10M	671.60M	693.60M
Diluted Earnings per Share	($1.22)	($1.11)	($0.94)	($0.82)	($0.61)	($6.24)	($1.47)	($0.96)
Weighted Average Diluted Shares Outstanding	216.85M	217.47M	273.88M	427M	640.80M	678.60M	671.60M	693.60M
Weighted Average Basic & Diluted Shares Outstanding	216.85M	217.47M	273.88M	427.02M	683.15M	674.43M	666.29M	691.64M

This table shows Clarivate's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Net Income / (Loss) Attributable to Common Shareholders	-4,434	304	25	-142	-6.60	-863	-94	-317	-66	-192	-104
Consolidated Net Income / (Loss)	-4,416	323	44	-123	12	-844	-75	-304	-66	-192	-104
Net Income / (Loss) Continuing Operations	-4,416	323	44	-123	12	-844	-75	-304	-66	-192	-104
Total Pre-Tax Income	-4,393	246	-20	-158	28	-862	-60	-311	-51	-132	-85
Total Operating Income	-4,375	319	55	-88	87	-788	5.00	-240	22	-62	-21
Total Gross Profit	412	438	399	445	427	452	403	437	412	435	387
Total Revenue	636	675	629	669	647	684	621	650	622	663	594
Operating Revenue	636	675	629	669	647	684	621	650	622	663	594
Total Cost of Revenue	224	237	230	224	221	232	218	214	210	228	207
Operating Cost of Revenue	224	237	230	224	221	232	218	214	210	228	207
Total Operating Expenses	4,787	120	345	533	339	1,240	398	677	390	498	408
Selling, General & Admin Expense	170	181	195	193	172	180	192	185	170	181	178
Depreciation Expense	170	189	173	178	177	181	179	184	177	186	185
Other Operating Expenses / (Income)	-27	-260	-32	15	-13	20	18	3.60	26	-99	19
Impairment Charge	4,449	67	9.40	147	3.70	859	9.50	304	18	230	25
Total Other Income / (Expense), net	-18	-73	-75	-70	-59	-74	-65	-71	-72	-70	-64
Interest & Investment Income	-	-	-74	-73	-72	-75	-70	-71	-72	-70	-64
Other Income / (Expense), net	53	4.10	-1.10	2.90	13	1.50	5.20	0.00	0.00	-	0.00
Income Tax Expense	22	-78	-64	-35	16	-18	15	-6.80	15	60	19
Preferred Stock Dividends Declared	19	19	19	19	19	19	19	13	0.00	-	0.00
Basic Earnings per Share	($6.58)	$0.48	$0.04	($0.21)	($0.01)	($1.29)	($0.14)	($0.46)	($0.09)	($0.27)	($0.15)
Weighted Average Basic Shares Outstanding	673.60M	676.10M	674.80M	675.90M	670.90M	671.60M	666.90M	685.60M	718.70M	693.60M	689.80M
Diluted Earnings per Share	($6.64)	$0.46	$0.04	($0.21)	($0.01)	($1.29)	($0.14)	($0.46)	($0.09)	($0.27)	($0.15)
Weighted Average Diluted Shares Outstanding	675.20M	678.60M	679.30M	675.90M	670.90M	671.60M	666.90M	685.60M	718.70M	693.60M	689.80M
Weighted Average Basic & Diluted Shares Outstanding	674.19M	674.43M	675.76M	676.23M	663.92M	666.29M	668.24M	724.14M	710.40M	691.64M	683.09M

This table details how cash moves in and out of Clarivate's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	-7.47	-52	51	196	315	-231	14	-76
Net Cash From Operating Activities	6.67	-26	118	264	324	509	744	647
Net Cash From Continuing Operating Activities	6.67	-26	118	264	324	509	744	647
Net Income / (Loss) Continuing Operations	-264	-242	-259	-351	-271	-3,960	-911	-637
Consolidated Net Income / (Loss)	-264	-242	-259	-351	-271	-3,960	-911	-637
Depreciation Expense	228	237	201	303	538	711	708	727
Amortization Expense	-	-	-	-	13	16	18	16
Non-Cash Adjustments To Reconcile Net Income	14	6.04	172	204	-25	4,059	1,060	565
Changes in Operating Assets and Liabilities, net	28	-27	3.72	107	68	-317	-131	-25
Net Cash From Investing Activities	-40	12	-141	-2,989	-4,045	57	-237	-237
Net Cash From Continuing Investing Activities	-40	12	-141	-2,989	-4,045	57	-237	-237
Purchase of Property, Plant & Equipment	-38	-45	-70	-108	-119	-203	-243	-289
Acquisitions	-7.40	-24	-71	-2,923	-3,930	-25	-5.40	-32
Divestitures	5.00	81	0.00	41	4.30	285	11	84
Net Cash From Financing Activities	23	-33	75	2,927	4,032	-759	-497	-470
Net Cash From Continuing Financing Activities	23	-33	75	2,927	4,032	-759	-497	-470
Repayment of Debt	-16	-77	-2,076	-176	-61	-494	-301	-217
Repurchase of Common Equity	-	-	-200	0.00	-159	-175	-100	-200
Payment of Dividends	-	-	0.00	0.00	-19	-75	-76	-38
Other Financing Activities, net	9.06	-0.90	681	239	-6.30	-15	-21	-16
Effect of Exchange Rate Changes	3.25	-5.19	-0.97	-5.00	3.70	-38	3.60	-15
Cash Interest Paid	115	122	101	98	182	252	274	265
Cash Income Taxes Paid	15	13	29	28	34	64	43	53

This table details how cash moves in and out of Clarivate's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Net Change in Cash & Equivalents	84	-100	18	69	-36	-37	10	-4.60	12	-93	59
Net Cash From Operating Activities	208	137	228	162	163	191	176	126	203	141	171
Net Cash From Continuing Operating Activities	208	137	228	162	163	191	176	126	203	141	171
Net Income / (Loss) Continuing Operations	-4,416	323	44	-123	12	-844	-75	-304	-66	-192	-104
Consolidated Net Income / (Loss)	-4,416	323	44	-123	12	-844	-75	-304	-66	-192	-104
Depreciation Expense	170	189	173	178	177	181	179	184	177	186	185
Amortization Expense	3.80	5.00	5.10	4.00	3.80	5.30	4.70	3.20	3.20	5.30	2.90
Non-Cash Adjustments To Reconcile Net Income	4,419	-222	1.00	129	7.60	922	25	300	46	194	32
Changes in Operating Assets and Liabilities, net	31	-158	5.30	-26	-37	-73	42	-57	42	-52	55
Net Cash From Investing Activities	-67	228	-60	-47	-63	-67	-64	-102	-92	21	-61
Net Cash From Continuing Investing Activities	-67	228	-60	-47	-63	-67	-64	-102	-92	21	-61
Purchase of Property, Plant & Equipment	-67	-46	-59	-58	-62	-64	-64	-66	-77	-82	-61
Net Cash From Financing Activities	-28	-492	-152	-46	-124	-174	-95	-26	-110	-240	-57
Net Cash From Continuing Financing Activities	-28	-492	-152	-46	-124	-174	-95	-26	-110	-240	-56
Repayment of Debt	-7.70	-469	-125	-25	-0.30	-150	-68	-5.50	-5.70	-138	0.00
Repurchase of Common Equity	-	-	-	-	-	-	-	-	-	-100	-50
Payment of Dividends	-19	-19	-19	-19	-19	-19	-19	-19	-	-	0.00
Other Financing Activities, net	-2.80	-1.90	-7.50	-2.20	-5.10	-5.80	-8.60	-1.30	-4.00	-1.70	-6.40
Effect of Exchange Rate Changes	-28	26	2.00	-0.30	-12	14	-6.30	-3.00	10	-16	5.10

This table presents Clarivate's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Total Assets	3,710	3,791	14,791	20,183	13,945	12,707	11,490
Total Current Assets	409	493	1,148	1,637	1,395	1,462	1,245
Cash & Equivalents	26	76	258	431	357	371	295
Accounts Receivable	331	334	738	906	872	908	798
Prepaid Expenses	31	41	58	77	89	89	86
Other Current Assets	21	42	79	67	77	68	65
Other Current Nonoperating Assets	-	-	-	-	0.00	27	0.00
Plant, Property, & Equipment, net	21	18	36	84	55	52	54
Total Noncurrent Assets	3,301	3,298	13,607	18,462	12,495	11,193	10,192
Goodwill	1,283	1,328	6,043	7,905	2,877	2,024	1,567
Intangible Assets	1,959	1,829	7,370	10,392	9,438	9,007	8,441
Noncurrent Deferred & Refundable Income Taxes	12	19	30	28	24	47	49
Other Noncurrent Operating Assets	27	104	164	137	157	116	136
Total Liabilities & Shareholders' Equity	3,710	3,791	14,791	20,183	13,945	12,707	11,490
Total Liabilities	2,659	2,543	5,756	8,257	7,132	6,715	6,351
Total Current Liabilities	644	651	1,423	1,902	1,560	1,600	1,434
Accounts Payable	38	26	82	129	101	144	125
Accrued Expenses	-	159	570	529	353	315	310
Current Deferred Revenue	391	407	707	1,030	948	983	859
Current Employee Benefit Liabilities	-	-	-	151	132	127	119
Other Current Liabilities	154	22	35	32	26	24	21
Other Current Nonoperating Liabilities	0.00	27	0.00	-	0.00	6.70	0.00
Total Noncurrent Liabilities	2,015	1,892	4,333	6,355	5,573	5,115	4,918
Long-Term Debt	1,930	1,629	3,458	5,456	5,005	4,721	4,519
Noncurrent Deferred Revenue	17	20	41	54	39	39	17
Noncurrent Deferred & Payable Income Tax Liabilities	43	49	367	380	316	250	273
Other Noncurrent Operating Liabilities	25	195	467	465	213	105	109
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,051	1,249	9,035	11,926	6,813	5,992	5,139
Total Preferred & Common Equity	1,051	1,249	9,035	11,926	6,813	5,992	5,139
Preferred Stock	-	-	0.00	1,393	1,393	1,393	0.00
Total Common Equity	1,051	1,249	9,035	10,533	5,420	4,600	5,139
Common Stock	1,678	2,144	9,989	11,828	11,745	11,741	12,979
Retained Earnings	-632	-891	-1,251	-1,604	-5,659	-6,646	-7,314
Accumulated Other Comprehensive Income / (Loss)	5.36	-4.88	492	327	-666	-495	-526

This table presents Clarivate's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025
Total Assets	13,749	13,940	13,706	13,418	12,505	12,078	12,031	11,493
Total Current Assets	1,452	1,451	1,418	1,375	1,391	1,335	1,339	1,354
Cash & Equivalents	446	364	436	399	362	376	389	354
Accounts Receivable	749	839	770	767	823	796	772	831
Prepaid Expenses	99	111	102	100	100	87	98	101
Other Current Assets	150	127	77	75	68	75	81	69
Plant, Property, & Equipment, net	57	52	51	50	49	46	47	55
Total Noncurrent Assets	12,240	12,436	12,237	11,994	11,065	10,697	10,644	10,083
Goodwill	2,804	2,892	2,896	2,865	2,023	1,737	1,737	1,567
Intangible Assets	9,249	9,397	9,186	8,955	8,874	8,771	8,727	8,341
Noncurrent Deferred & Refundable Income Taxes	24	25	27	26	47	49	51	49
Other Noncurrent Operating Assets	163	123	129	147	121	140	130	127
Total Liabilities & Shareholders' Equity	13,749	13,940	13,706	13,418	12,505	12,078	12,031	11,493
Total Liabilities	7,674	6,980	6,767	6,736	6,616	6,473	6,517	6,466
Total Current Liabilities	1,633	1,610	1,498	1,469	1,615	1,485	1,526	1,541
Accounts Payable	106	102	108	99	103	128	127	120
Accrued Expenses	417	362	317	347	365	314	375	333
Current Deferred Revenue	858	1,040	940	889	1,010	912	890	979
Current Employee Benefit Liabilities	108	80	101	103	86	107	112	88
Other Current Liabilities	29	25	24	24	24	23	22	21
Total Noncurrent Liabilities	6,042	5,371	5,269	5,267	5,002	4,988	4,992	4,925
Long-Term Debt	5,417	4,885	4,863	4,866	4,638	4,635	4,633	4,521
Noncurrent Deferred & Payable Income Tax Liabilities	351	314	262	256	246	229	227	276
Other Noncurrent Operating Liabilities	236	134	106	109	100	100	110	128
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	6,075	6,959	6,938	6,682	5,888	5,605	5,514	5,027
Total Preferred & Common Equity	6,075	6,959	6,938	6,682	5,888	5,605	5,514	5,027
Total Common Equity	4,682	5,567	5,546	5,290	4,496	5,605	5,514	5,027
Common Stock	11,718	11,778	11,809	11,730	11,747	13,158	13,069	12,935
Retained Earnings	-5,955	-5,634	-5,776	-5,783	-6,739	-7,056	-7,122	-7,417
Accumulated Other Comprehensive Income / (Loss)	-1,070	-578	-488	-658	-512	-497	-434	-491

This table displays calculated financial ratios and metrics derived from Clarivate's official financial filings.

Metric	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	5.54%	0.61%	28.71%	49.66%	41.71%	-1.17%	-2.74%
EBITDA Growth	0.00%	61.50%	-16.51%	-43.72%	782.36%	-648.67%	100.26%	6,042.86%
EBIT Growth	0.00%	28.10%	14.16%	-166.03%	97.64%	-65,142.11%	80.67%	62.38%
NOPAT Growth	0.00%	28.10%	21.97%	55.99%	-139.67%	-4,412.18%	81.28%	62.49%
Net Income Growth	0.00%	8.25%	-6.80%	-35.56%	22.85%	-1,364.03%	76.99%	30.13%
EPS Growth	0.00%	9.02%	15.32%	12.77%	25.61%	-922.95%	76.44%	34.69%
Operating Cash Flow Growth	0.00%	-491.48%	550.50%	124.10%	22.88%	57.29%	46.12%	-13.11%
Free Cash Flow Firm Growth	0.00%	0.00%	103.91%	-7,908.13%	50.86%	156.43%	-76.16%	23.02%
Invested Capital Growth	0.00%	0.00%	-5.92%	331.76%	37.36%	-31.88%	-9.93%	-9.30%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	19.05%	5.93%	4.50%	0.32%	-0.80%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%	-58.53%	4.18%	10.93%	-99.32%	284.33%
EBIT Q/Q Growth	0.00%	0.00%	0.00%	-192.41%	-249.96%	7.98%	-284.07%	72.82%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	56.03%	32.28%	6.80%	-151.28%	72.48%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	25.30%	-56.54%	9.89%	-455.80%	50.60%
EPS Q/Q Growth	0.00%	0.00%	0.00%	38.35%	-48.78%	8.24%	-625.00%	51.52%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	0.00%	97.95%	-26.57%	30.36%	7.82%	-7.12%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%	43.78%	216.95%	-39.58%	15.42%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	230.58%	41.82%	2.76%	-7.20%	-4.05%
Profitability Metrics	-	-	-	-	-	-	-	-
Gross Margin	57.04%	55.57%	63.87%	65.01%	66.64%	64.13%	65.52%	66.00%
EBITDA Margin	8.87%	13.58%	11.27%	4.93%	29.05%	-112.49%	0.29%	18.50%
Operating Margin	-16.02%	-10.92%	-8.47%	-2.89%	-4.64%	-147.59%	-27.95%	-10.78%
EBIT Margin	-16.02%	-10.92%	-9.31%	-19.25%	-0.30%	-139.82%	-27.34%	-10.58%
Profit (Net Income) Margin	-28.76%	-25.00%	-26.54%	-27.96%	-14.41%	-148.89%	-34.66%	-24.90%
Tax Burden Percent	92.53%	102.39%	104.11%	99.24%	104.76%	99.28%	90.00%	114.97%
Interest Burden Percent	193.99%	223.74%	273.78%	146.35%	4,529.82%	107.27%	140.86%	204.81%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	-4.91%	-1.97%	-0.34%	-0.42%	-19.43%	-4.72%	-1.96%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	-22.02%	-13.28%	-13.88%	-5.59%	-44.82%	-13.56%	-12.34%
Return on Net Nonoperating Assets (RNNOA)	0.00%	-41.19%	-20.52%	-6.48%	-2.16%	-22.84%	-9.51%	-9.48%
Return on Equity (ROE)	0.00%	-46.10%	-22.50%	-6.82%	-2.58%	-42.27%	-14.23%	-11.44%
Cash Return on Invested Capital (CROIC)	0.00%	-204.91%	4.13%	-125.12%	-31.90%	18.50%	5.73%	7.80%
Operating Return on Assets (OROA)	0.00%	-2.85%	-2.42%	-2.60%	-0.03%	-21.79%	-5.39%	-2.24%
Return on Assets (ROA)	0.00%	-6.53%	-6.90%	-3.77%	-1.55%	-23.21%	-6.84%	-5.26%
Return on Common Equity (ROCE)	0.00%	-46.10%	-22.50%	-6.82%	-2.41%	-35.99%	-11.14%	-10.01%
Return on Equity Simple (ROE_SIMPLE)	0.00%	-23.05%	-20.71%	-3.88%	-2.27%	-58.13%	-15.21%	-12.39%
Net Operating Profit after Tax (NOPAT)	-103	-74	-58	-25	-61	-2,748	-514	-193
NOPAT Margin	-11.22%	-7.64%	-5.93%	-2.03%	-3.24%	-103.31%	-19.56%	-7.55%
Net Nonoperating Expense Percent (NNEP)	0.00%	17.12%	11.31%	13.54%	5.17%	25.39%	8.84%	10.38%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-23.25%	-4.80%	-2.00%
Cost of Revenue to Revenue	42.96%	44.43%	36.13%	34.99%	33.36%	35.87%	34.48%	34.00%
SG&A Expenses to Revenue	37.39%	42.65%	48.75%	43.43%	34.26%	27.44%	28.14%	28.46%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	73.06%	66.48%	72.34%	67.91%	71.28%	211.72%	93.47%	76.78%
Earnings before Interest and Taxes (EBIT)	-147	-106	-91	-241	-5.70	-3,719	-719	-270
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	81	132	110	62	545	-2,992	7.70	473
Valuation Ratios	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	4.11	1.99	1.43	1.04	1.34	0.70
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.00	0.00	5.26	14.36	8.02	2.11	2.34	1.41
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	2.36	1.73	1.27	1.02	1.15	0.84
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	6.87	16.92	11.37	4.39	4.52	3.06
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	60.93	343.32	39.13	0.00	1,544.28	16.56
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	56.89	80.52	65.90	22.90	15.98	12.11
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	55.35	0.00	0.00	4.46	19.06	10.21
Leverage & Solvency	-	-	-	-	-	-	-	-
Debt to Equity	0.00	1.89	1.31	0.39	0.46	0.73	0.79	0.88
Long-Term Debt to Equity	0.00	1.84	1.30	0.38	0.46	0.73	0.79	0.88
Financial Leverage	0.00	1.87	1.55	0.47	0.39	0.51	0.70	0.77
Leverage Ratio	0.00	3.53	3.26	1.81	1.67	1.82	2.08	2.17
Compound Leverage Factor	0.00	7.90	8.93	2.64	75.58	1.95	2.93	4.45
Debt to Total Capital	0.00%	65.45%	56.74%	27.84%	31.51%	42.35%	44.07%	46.79%
Short-Term Debt to Total Capital	0.00%	1.98%	0.31%	0.23%	0.18%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	63.47%	56.43%	27.62%	31.34%	42.35%	44.07%	46.79%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	8.00%	11.78%	13.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	0.00%	34.55%	43.26%	72.16%	60.49%	45.86%	42.93%	53.21%
Debt to EBITDA	0.00	15.14	14.91	56.42	10.06	-1.67	613.13	9.55
Net Debt to EBITDA	0.00	14.94	14.22	52.01	8.98	-1.55	564.99	8.93
Long-Term Debt to EBITDA	0.00	14.68	14.83	55.95	10.01	-1.67	613.13	9.55
Debt to NOPAT	0.00	-26.90	-28.36	-137.21	-90.10	-1.82	-9.18	-23.42
Net Debt to NOPAT	0.00	-26.55	-27.04	-126.49	-80.45	-1.69	-8.46	-21.89
Long-Term Debt to NOPAT	0.00	-26.09	-28.21	-136.08	-89.59	-1.82	-9.18	-23.42
Altman Z-Score	0.00	0.00	1.01	1.77	1.06	-0.80	-0.18	-0.43
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	6.64%	14.86%	21.75%	12.51%
Liquidity Ratios	-	-	-	-	-	-	-	-
Current Ratio	0.00	0.63	0.76	0.81	0.86	0.89	0.91	0.87
Quick Ratio	0.00	0.55	0.63	0.70	0.70	0.79	0.80	0.76
Cash Flow Metrics	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-3,090	121	-9,437	-4,637	2,617	624	767
Operating Cash Flow to CapEx	17.64%	-57.48%	168.37%	244.66%	273.25%	251.01%	306.89%	223.66%
Free Cash Flow to Firm to Interest Expense	0.00	-23.62	0.77	-84.34	-18.37	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.05	-0.20	0.75	2.35	1.28	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	-0.23	-0.55	0.30	1.39	0.81	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-
Asset Turnover	0.00	0.26	0.26	0.14	0.11	0.16	0.20	0.21
Accounts Receivable Turnover	0.00	2.92	2.93	2.34	2.28	2.99	2.95	3.00
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	46.92	50.38	46.18	31.26	38.46	49.55	48.65
Accounts Payable Turnover	0.00	11.20	10.85	8.09	5.93	8.27	7.38	6.47
Days Sales Outstanding (DSO)	0.00	124.86	124.59	155.94	159.87	122.03	123.60	121.82
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	32.59	33.64	45.12	61.57	44.11	49.43	56.40
Cash Conversion Cycle (CCC)	0.00	92.27	90.95	110.82	98.29	77.92	74.17	65.42
Capital & Investment Metrics	-	-	-	-	-	-	-	-
Invested Capital	0.00	3,016	2,837	12,249	16,825	11,461	10,323	9,363
Invested Capital Turnover	0.00	0.64	0.33	0.17	0.13	0.19	0.24	0.26
Increase / (Decrease) in Invested Capital	0.00	3,016	-179	9,412	4,576	-5,365	-1,138	-960
Enterprise Value (EV)	0.00	0.00	6,690	21,217	21,339	11,664	11,891	7,832
Market Capitalization	0.00	0.00	5,128	18,003	15,048	5,623	6,148	3,609
Book Value per Share	$0.00	$4.83	$4.09	$14.91	$16.46	$8.04	$6.93	$7.23
Tangible Book Value per Share	$0.00	($10.07)	($6.25)	($7.23)	($12.14)	($10.23)	($9.69)	($6.85)
Total Capital	0.00	3,041	2,886	12,521	17,413	11,818	10,713	9,658
Total Debt	0.00	1,991	1,638	3,487	5,487	5,005	4,721	4,519
Total Long-Term Debt	0.00	1,930	1,629	3,458	5,456	5,005	4,721	4,519
Net Debt	0.00	1,965	1,561	3,214	4,899	4,648	4,350	4,224
Capital Expenditures (CapEx)	38	45	70	108	119	203	243	289
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	-200	-225	-519	-822	-521	-509	-484
Debt-free Net Working Capital (DFNWC)	0.00	-175	-149	-247	-234	-165	-138	-189
Net Working Capital (NWC)	0.00	-235	-158	-276	-265	-165	-138	-189
Net Nonoperating Expense (NNE)	161	168	201	325	210	1,212	397	444
Net Nonoperating Obligations (NNO)	0.00	1,965	1,588	3,214	4,899	4,648	4,330	4,224
Total Depreciation and Amortization (D&A)	228	237	201	303	551	727	727	743
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	-20.69%	-23.10%	-41.41%	-43.79%	-19.60%	-19.34%	-18.93%
Debt-free Net Working Capital to Revenue	0.00%	-18.04%	-15.28%	-19.69%	-12.48%	-6.19%	-5.24%	-7.39%
Net Working Capital to Revenue	0.00%	-24.28%	-16.21%	-21.97%	-14.11%	-6.19%	-5.24%	-7.39%
Earnings Adjustments	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	($147.14)	($0.77)	($0.25)	($0.49)	$0.00	($1.47)	($0.96)
Adjusted Weighted Average Basic Shares Outstanding	0.00	1.65M	361.66M	607.98M	630.98M	0.00	671.60M	693.60M
Adjusted Diluted Earnings per Share	$0.00	($147.14)	($0.77)	($0.25)	($0.61)	$0.00	($1.47)	($0.96)
Adjusted Weighted Average Diluted Shares Outstanding	0.00	1.65M	361.66M	607.98M	640.77M	0.00	671.60M	693.60M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	($0.77)	($0.25)	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	217.47M	273.88M	428.60M	683.15M	0.00	666.29M	691.64M
Normalized Net Operating Profit after Tax (NOPAT)	-35	-74	-34	14	30	413	200	199
Normalized NOPAT Margin	-3.87%	-7.64%	-3.48%	1.11%	1.59%	15.53%	7.59%	7.79%
Pre Tax Income Margin	-31.08%	-24.42%	-25.50%	-28.17%	-13.76%	-149.98%	-38.52%	-21.66%
Debt Service Ratios	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-1.06	-0.81	-0.58	-2.16	-0.02	0.00	0.00	0.00
NOPAT to Interest Expense	-0.74	-0.57	-0.37	-0.23	-0.24	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	-1.34	-1.16	-1.02	-3.12	-0.49	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	-1.02	-0.91	-0.81	-1.19	-0.71	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	-6.99%	-1.90%	-8.29%	-5.92%
Augmented Payout Ratio	0.00%	0.00%	-77.33%	0.00%	-65.92%	-6.32%	-19.26%	-37.33%

This table displays calculated financial ratios and metrics derived from Clarivate's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	43.79%	20.44%	-5.00%	-2.59%	1.81%	1.24%	-1.26%	-2.77%	-3.86%	-3.03%	-4.43%
EBITDA Growth	-1,884.26%	245.88%	-28.93%	-69.28%	106.76%	-216.31%	-15.96%	-154.19%	-27.92%	121.48%	-13.79%
EBIT Growth	-4,537.27%	0.00%	-63.18%	-163.17%	102.31%	-343.86%	-80.93%	-181.03%	-78.26%	92.08%	-303.92%
NOPAT Growth	-24,139.21%	1,778.16%	5.09%	-183.77%	101.26%	-231.56%	-90.84%	-171.80%	-60.49%	92.10%	-516.00%
Net Income Growth	-15,647.54%	390.31%	-37.41%	-297.28%	100.28%	-360.95%	-272.41%	-147.20%	-633.33%	77.27%	-38.53%
EPS Growth	-5,433.33%	560.00%	166.67%	0.00%	99.85%	-380.43%	-450.00%	-119.05%	-800.00%	79.07%	-7.14%
Operating Cash Flow Growth	374.43%	648.09%	237.54%	67.08%	-21.37%	39.44%	-22.55%	-22.29%	24.17%	-25.98%	-2.84%
Free Cash Flow Firm Growth	71.13%	227.01%	217.69%	218.25%	102.89%	-89.86%	-74.80%	-72.42%	1,932.57%	56.35%	-28.53%
Invested Capital Growth	-6.00%	-31.88%	-31.22%	-29.77%	-0.26%	-9.93%	-11.49%	-13.02%	-12.28%	-9.30%	-9.44%
Revenue Q/Q Growth	-7.41%	6.23%	-6.84%	6.31%	-3.23%	5.64%	-9.14%	4.68%	-4.32%	6.56%	-10.45%
EBITDA Q/Q Growth	-1,417.79%	112.45%	-55.23%	-58.17%	189.97%	-314.19%	132.35%	-126.97%	485.69%	-36.17%	29.85%
EBIT Q/Q Growth	-3,296.67%	107.46%	-83.42%	-259.63%	216.86%	-888.28%	101.30%	-2,452.94%	109.04%	-387.10%	66.61%
NOPAT Q/Q Growth	-4,250.80%	113.69%	-90.89%	-261.72%	162.20%	-1,535.22%	100.63%	-4,900.00%	109.04%	-387.10%	66.61%
Net Income Q/Q Growth	-7,176.12%	107.32%	-86.55%	-382.99%	109.99%	-6,960.98%	91.11%	-305.73%	78.44%	-192.38%	45.83%
EPS Q/Q Growth	0.00%	106.93%	-91.30%	-625.00%	95.24%	-12,800.00%	89.15%	-228.57%	80.43%	-200.00%	44.44%
Operating Cash Flow Q/Q Growth	113.79%	-34.12%	66.18%	-28.62%	0.62%	16.83%	-7.70%	-28.38%	60.78%	-30.36%	21.16%
Free Cash Flow Firm Q/Q Growth	41.40%	345.98%	-9.34%	-9.52%	-98.57%	762.87%	125.38%	-0.98%	5.55%	-33.63%	3.03%
Invested Capital Q/Q Growth	-30.93%	2.76%	0.09%	-1.14%	-1.91%	-7.20%	-1.64%	-2.85%	-1.07%	-4.05%	-1.80%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	64.81%	64.90%	63.49%	66.48%	65.91%	66.08%	64.94%	67.15%	66.23%	65.66%	65.13%
EBITDA Margin	-652.57%	76.47%	36.75%	14.46%	43.33%	-87.85%	31.28%	-8.06%	32.48%	19.46%	28.21%
Operating Margin	-688.25%	47.16%	8.68%	-13.20%	13.47%	-115.28%	0.80%	-36.91%	3.49%	-9.40%	-3.50%
EBIT Margin	-679.86%	47.77%	8.50%	-12.77%	15.42%	-115.07%	1.64%	-36.91%	3.49%	-9.40%	-3.50%
Profit (Net Income) Margin	-694.59%	47.89%	6.91%	-18.41%	1.90%	-123.43%	-12.07%	-46.79%	-10.54%	-28.93%	-17.50%
Tax Burden Percent	100.50%	131.68%	-216.42%	77.71%	44.09%	97.91%	125.00%	97.81%	129.90%	145.08%	122.09%
Interest Burden Percent	101.65%	76.13%	-37.57%	185.48%	27.96%	109.56%	-588.24%	129.63%	-232.72%	212.20%	409.13%
Effective Tax Rate	0.00%	-31.68%	0.00%	0.00%	55.91%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-106.55%	11.68%	1.13%	-1.75%	1.40%	-19.48%	0.14%	-6.34%	0.60%	-1.71%	-0.64%
ROIC Less NNEP Spread (ROIC-NNEP)	-151.27%	9.67%	1.25%	-3.04%	0.85%	-25.99%	-1.65%	-9.49%	-1.26%	-5.17%	-2.76%
Return on Net Nonoperating Assets (RNNOA)	-53.94%	4.93%	0.63%	-1.61%	0.63%	-18.22%	-1.13%	-6.55%	-0.90%	-3.98%	-2.13%
Return on Equity (ROE)	-160.49%	16.61%	1.77%	-3.36%	2.03%	-37.70%	-0.99%	-12.89%	-0.29%	-5.68%	-2.77%
Cash Return on Invested Capital (CROIC)	-19.44%	18.50%	17.51%	14.14%	9.27%	5.73%	7.11%	7.75%	6.37%	7.80%	7.73%
Operating Return on Assets (OROA)	-108.52%	7.45%	1.33%	-2.05%	2.97%	-22.70%	0.33%	-7.45%	0.71%	-1.99%	-0.74%
Return on Assets (ROA)	-110.87%	7.46%	1.08%	-2.95%	0.37%	-24.35%	-2.39%	-9.45%	-2.14%	-6.11%	-3.69%
Return on Common Equity (ROCE)	-134.14%	14.14%	1.50%	-2.84%	1.59%	-29.50%	-0.78%	-11.46%	-0.26%	-4.97%	-2.42%
Return on Equity Simple (ROE_SIMPLE)	-72.35%	0.00%	-57.28%	-60.13%	3.83%	0.00%	-17.49%	-21.61%	-23.38%	0.00%	-13.24%
Net Operating Profit after Tax (NOPAT)	-3,063	419	38	-62	38	-552	3.50	-168	15	-44	-15
NOPAT Margin	-481.77%	62.10%	6.08%	-9.24%	5.94%	-80.70%	0.56%	-25.83%	2.44%	-6.58%	-2.45%
Net Nonoperating Expense Percent (NNEP)	44.72%	2.01%	-0.11%	1.29%	0.55%	6.51%	1.79%	3.15%	1.86%	3.46%	2.12%
Return On Investment Capital (ROIC_SIMPLE)	-	3.55%	-	-	-	-5.15%	-	-	-	-0.45%	-0.15%
Cost of Revenue to Revenue	35.19%	35.10%	36.51%	33.52%	34.09%	33.92%	35.06%	32.85%	33.77%	34.34%	34.87%
SG&A Expenses to Revenue	26.66%	26.74%	30.96%	28.84%	26.56%	26.34%	30.89%	28.48%	27.27%	27.27%	30.05%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	753.06%	17.74%	54.81%	79.68%	52.44%	181.37%	64.13%	104.06%	62.75%	75.05%	68.64%
Earnings before Interest and Taxes (EBIT)	-4,322	323	54	-85	100	-787	10	-240	22	-62	-21
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-4,148	516	231	97	280	-601	194	-52	202	129	168
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.35	1.04	1.14	1.16	0.86	1.34	1.10	0.68	0.93	0.70	0.54
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	2.48	2.11	2.41	2.47	1.73	2.34	1.88	1.46	1.99	1.41	1.07
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	25.11	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	3.98%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.14	1.02	1.07	1.08	0.93	1.15	1.04	0.82	0.96	0.84	0.75
Enterprise Value to Revenue (EV/Rev)	5.00	4.39	4.66	4.70	3.97	4.52	4.05	3.10	3.64	3.06	2.72
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	9.24	1,544.28	0.00	0.00	0.00	16.56	15.43
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	26.61	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	10.36	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	32.60	22.90	18.28	16.68	15.05	15.98	15.30	12.28	13.48	12.11	10.73
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	4.46	4.97	6.31	10.07	19.06	13.79	9.82	14.12	10.21	9.21
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.90	0.73	0.70	0.70	0.73	0.79	0.79	0.83	0.84	0.88	0.90
Long-Term Debt to Equity	0.89	0.73	0.70	0.70	0.73	0.79	0.79	0.83	0.84	0.88	0.90
Financial Leverage	0.36	0.51	0.51	0.53	0.75	0.70	0.68	0.69	0.71	0.77	0.77
Leverage Ratio	1.88	1.82	1.80	1.81	2.13	2.08	2.06	2.06	2.09	2.17	2.20
Compound Leverage Factor	1.91	1.39	-0.68	3.36	0.60	2.28	-12.11	2.66	-4.86	4.61	8.99
Debt to Total Capital	47.40%	42.35%	41.25%	41.21%	42.14%	44.07%	44.06%	45.27%	45.66%	46.79%	47.35%
Short-Term Debt to Total Capital	0.50%	0.00%	0.01%	0.01%	0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	46.91%	42.35%	41.24%	41.20%	42.13%	44.07%	44.06%	45.27%	45.66%	46.79%	47.35%
Preferred Equity to Total Capital	12.06%	11.78%	11.76%	11.80%	12.06%	13.00%	13.23%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	40.54%	45.86%	47.00%	46.99%	45.80%	42.93%	42.71%	54.73%	54.34%	53.21%	52.65%
Debt to EBITDA	-1.63	-1.67	-1.58	-1.47	4.33	613.13	-158.83	-26.00	-18.05	9.55	10.13
Net Debt to EBITDA	-1.49	-1.55	-1.46	-1.34	3.97	564.99	-146.44	-23.89	-16.54	8.93	9.34
Long-Term Debt to EBITDA	-1.61	-1.67	-1.58	-1.47	4.33	613.13	-158.83	-26.00	-18.05	9.55	10.13
Debt to NOPAT	-1.86	-1.82	-1.78	-1.70	4.85	-9.18	-8.45	-7.07	-6.61	-23.42	-21.43
Net Debt to NOPAT	-1.70	-1.69	-1.65	-1.54	4.45	-8.46	-7.79	-6.50	-6.05	-21.89	-19.75
Long-Term Debt to NOPAT	-1.84	-1.82	-1.78	-1.70	4.85	-9.18	-8.45	-7.07	-6.61	-23.42	-21.43
Altman Z-Score	-0.98	0.16	0.17	0.14	0.01	-0.19	-0.12	-0.33	-0.15	-0.37	-0.46
Noncontrolling Interest Sharing Ratio	16.42%	14.86%	14.92%	15.49%	21.83%	21.75%	21.68%	11.10%	11.42%	12.51%	12.76%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.89	0.89	0.90	0.95	0.94	0.91	0.86	0.90	0.88	0.87	0.88
Quick Ratio	0.73	0.79	0.75	0.81	0.79	0.80	0.73	0.79	0.76	0.76	0.77
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-2,351	5,784	5,244	4,745	68	586	1,321	1,308	1,381	917	944
Operating Cash Flow to CapEx	308.31%	295.04%	383.64%	281.94%	264.83%	298.75%	273.60%	191.50%	264.88%	171.90%	281.12%
Free Cash Flow to Firm to Interest Expense	-32.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	2.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	1.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.16	0.16	0.16	0.16	0.19	0.20	0.20	0.20	0.20	0.21	0.21
Accounts Receivable Turnover	3.74	2.99	3.09	3.30	3.46	2.95	3.15	3.32	3.35	3.00	3.06
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	59.99	38.46	39.71	40.92	49.16	49.55	51.64	53.82	53.14	48.65	48.50
Accounts Payable Turnover	9.03	8.27	8.53	8.13	8.89	7.38	8.75	7.48	7.74	6.47	7.71
Days Sales Outstanding (DSO)	97.47	122.03	118.00	110.67	105.55	123.60	115.69	109.82	108.95	121.82	119.30
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	40.42	44.11	42.77	44.88	41.07	49.43	41.70	48.79	47.16	56.40	47.35
Cash Conversion Cycle (CCC)	57.05	77.92	75.23	65.80	64.48	74.17	73.99	61.03	61.79	65.42	71.96
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	11,153	11,461	11,471	11,340	11,123	10,323	10,153	9,864	9,758	9,363	9,194
Invested Capital Turnover	0.22	0.19	0.19	0.19	0.24	0.24	0.24	0.25	0.25	0.26	0.26
Increase / (Decrease) in Invested Capital	-711	-5,365	-5,206	-4,807	-30	-1,138	-1,318	-1,476	-1,366	-960	-959
Enterprise Value (EV)	12,737	11,664	12,237	12,254	10,390	11,891	10,602	8,061	9,385	7,832	6,885
Market Capitalization	6,324	5,623	6,333	6,440	4,538	6,148	4,933	3,802	5,141	3,609	2,718
Book Value per Share	$6.95	$8.04	$8.25	$8.21	$7.82	$6.93	$6.74	$8.39	$7.61	$7.23	$7.27
Tangible Book Value per Share	($10.94)	($10.23)	($9.97)	($9.67)	($9.66)	($9.69)	($9.60)	($7.34)	($6.84)	($6.85)	($7.06)
Total Capital	11,549	11,818	11,845	11,803	11,550	10,713	10,526	10,240	10,146	9,658	9,548
Total Debt	5,475	5,005	4,886	4,864	4,868	4,721	4,638	4,635	4,633	4,519	4,521
Total Long-Term Debt	5,417	5,005	4,885	4,863	4,866	4,721	4,638	4,635	4,633	4,519	4,521
Net Debt	5,020	4,648	4,512	4,421	4,460	4,350	4,276	4,259	4,244	4,224	4,167
Capital Expenditures (CapEx)	67	46	59	58	62	64	64	66	77	82	61
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-578	-521	-532	-522	-500	-509	-586	-527	-575	-484	-540
Debt-free Net Working Capital (DFNWC)	-123	-165	-157	-79	-93	-138	-224	-150	-187	-189	-186
Net Working Capital (NWC)	-181	-165	-158	-80	-94	-138	-224	-150	-187	-189	-186
Net Nonoperating Expense (NNE)	1,353	96	-5.28	61	26	292	79	136	81	148	89
Net Nonoperating Obligations (NNO)	5,078	4,648	4,512	4,402	4,441	4,330	4,265	4,259	4,244	4,224	4,167
Total Depreciation and Amortization (D&A)	174	194	178	182	181	186	184	188	180	191	188
Debt-free, Cash-free Net Working Capital to Revenue	-22.71%	-19.60%	-20.24%	-20.02%	-19.08%	-19.34%	-22.35%	-20.24%	-22.31%	-18.93%	-21.36%
Debt-free Net Working Capital to Revenue	-4.84%	-6.19%	-5.99%	-3.04%	-3.54%	-5.24%	-8.55%	-5.78%	-7.24%	-7.39%	-7.37%
Net Working Capital to Revenue	-7.10%	-6.19%	-6.03%	-3.08%	-3.58%	-5.24%	-8.55%	-5.78%	-7.24%	-7.39%	-7.37%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($6.58)	$0.48	$0.04	($0.21)	($0.01)	($1.29)	($0.14)	($0.46)	($0.09)	($0.27)	($0.15)
Adjusted Weighted Average Basic Shares Outstanding	673.55M	676.10M	674.80M	675.90M	670.90M	671.60M	666.90M	685.60M	718.70M	693.60M	689.80M
Adjusted Diluted Earnings per Share	($6.64)	$0.46	$0.04	($0.21)	($0.01)	($1.29)	($0.14)	($0.46)	($0.09)	($0.27)	($0.15)
Adjusted Weighted Average Diluted Shares Outstanding	675.18M	678.60M	679.30M	675.90M	670.90M	671.60M	666.90M	685.60M	718.70M	693.60M	689.80M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	674.19M	674.43M	675.76M	676.23M	663.92M	666.29M	668.24M	724.14M	710.40M	691.64M	683.09M
Normalized Net Operating Profit after Tax (NOPAT)	70	270	45	41	64	50	10	44	28	117	2.73
Normalized NOPAT Margin	10.95%	39.98%	7.12%	6.19%	9.83%	7.29%	1.63%	6.84%	4.44%	17.65%	0.46%
Pre Tax Income Margin	-691.11%	36.37%	-3.20%	-23.68%	4.31%	-126.06%	-9.66%	-47.84%	-8.12%	-19.94%	-14.33%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-60.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	-42.83	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	-61.39	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	-43.78	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-1.72%	-1.90%	-1.89%	-1.81%	29.48%	-8.29%	-7.33%	-6.24%	-4.38%	-5.92%	-2.82%
Augmented Payout Ratio	-7.84%	-6.32%	-1.89%	-1.81%	68.53%	-19.26%	-7.33%	-6.24%	-12.14%	-37.33%	-40.38%

Frequently Asked Questions About Clarivate's Financials

When does Clarivate's fiscal year end?

According to the most recent income statement we have on file, Clarivate's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Clarivate's net income changed over the last 7 years?

Clarivate's net income appears to be on an upward trend, with a most recent value of -$636.70 million in 2024, rising from -$263.93 million in 2017. The previous period was -$911.20 million in 2023. Find out what analysts predict for Clarivate in the coming months.

What is Clarivate's operating income?

Clarivate's total operating income in 2024 was -$275.60 million, based on the following breakdown:

Total Gross Profit: $1.69 billion
Total Operating Expenses: $1.96 billion

How has Clarivate's revenue changed over the last 7 years?

Over the last 7 years, Clarivate's total revenue changed from $917.63 million in 2017 to $2.56 billion in 2024, a change of 178.6%.

How much debt does Clarivate have?

Clarivate's total liabilities were at $6.35 billion at the end of 2024, a 5.4% decrease from 2023, and a 138.9% increase since 2018.

How much cash does Clarivate have?

In the past 6 years, Clarivate's cash and equivalents has ranged from $25.58 million in 2018 to $430.90 million in 2021, and is currently $295.20 million as of their latest financial filing in 2024.

How has Clarivate's book value per share changed over the last 7 years?

Over the last 7 years, Clarivate's book value per share changed from 0.00 in 2017 to 7.23 in 2024, a change of 723.4%.

Related Companies

This page (NYSE:CLVT) was last updated on 6/17/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Clarivate (CLVT) Financials

Frequently Asked Questions About Clarivate's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Clarivate (CLVT) Financials

Annual Income Statements for Clarivate

Quarterly Income Statements for Clarivate

Annual Cash Flow Statements for Clarivate

Quarterly Cash Flow Statements for Clarivate

Annual Balance Sheets for Clarivate

Quarterly Balance Sheets for Clarivate

Annual Metrics And Ratios for Clarivate

Quarterly Metrics And Ratios for Clarivate

Frequently Asked Questions About Clarivate's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools